Semin Musculoskelet Radiol 2012; 16(05): 377-388
DOI: 10.1055/s-0032-1329881
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Whole-Body MRI for Inflammatory Arthritis and Other Multifocal Rheumatoid Diseases

Sabine Weckbach
1   Institute for Clinical Radiology, Ludwig-Maximilians-University Hospital Munich, Munich, Germany
2   Department of Diagnostic and Interventional Radiology, University Hospital Heidelberg, Heidelberg, Germany
› Author Affiliations
Further Information

Publication History

Publication Date:
04 December 2012 (online)

Abstract

Whole-body MRI (WBMRI) is an excellent tool for the imaging of rheumatologic diseases with a multifocal and systemic character. These include the different forms of spondyloarthritis, chronic recurrent multifocal osteomyelitis (CRMO), and inflammatory muscle diseases along with diseases such as systemic lupus and systemic sclerosis that show organ involvement. Although it is not recommended as a first-line investigation in every patient, it may add important information in difficult cases.

Currently WBMRI for inflammatory arthritis is mainly used in imaging the seronegative spondyloarthropathies. The technique visualizes most of the involved joints and soft tissue structures with both (early) active and chronic inflammatory changes in one examination. Different patterns of joint involvement can be recognized, with both the acute features of the disease and the longer term sequelae being shown. The technique also allows therapeutic response to be assessed.

In CRMO, WBMRI is able to detect asymptomatic and radiographically occult multifocal lesions that typically show a symmetrical distribution predominating in the lower extremity.

In inflammatory muscle diseases, WBMRI is able to provide important information for biochemical and genetic differential diagnosis because there is growing knowledge of the correlation between typical patterns of disease and defined clinical entities. In addition, it helps in biopsy localization and is very well suited for assessing disease activity.

WBMRI is particularly useful for studying internal organ involvement, especially the brain, heart, and lungs in connective tissue diseases such as systemic lupus erythematosus in one whole-body exam.

 
  • References

  • 1 Lenk S, Fischer S, Kötter I, Claussen CD, Schlemmer HP. Possibilities of whole-body MRI for investigating musculoskeletal diseases. [in German]. Radiologe 2004; 44 (9) 844-853
  • 2 Schmidt GP, Reiser MF, Baur-Melnyk A. Whole-body imaging of the musculoskeletal system: the value of MR imaging. Skeletal Radiol 2007; 36 (12) 1109-1119
  • 3 Schmidt GP, Schoenberg SO, Reiser MF, Baur-Melnyk A. Whole-body MR imaging of bone marrow. Eur J Radiol 2005; 55 (1) 33-40
  • 4 Baur-Melnyk A, Buhmann S, Becker C , et al. Whole-body MRI versus whole-body MDCT for staging of multiple myeloma. AJR Am J Roentgenol 2008; 190 (4) 1097-1104
  • 5 Dinter DJ, Neff WK, Klaus J , et al. Comparison of whole-body MR imaging and conventional X-ray examination in patients with multiple myeloma and implications for therapy. Ann Hematol 2009; 88 (5) 457-464
  • 6 Leroy-Willig A. Quantitative MR evaluation of body composition in patients with Duchenne muscular dystrophy. Eur Radiol 2003; 13 (12) 2710-2711; author reply 2712
  • 7 Pichiecchio A, Uggetti C, Egitto MG , et al. Quantitative MR evaluation of body composition in patients with Duchenne muscular dystrophy. Eur Radiol 2002; 12 (11) 2704-2709
  • 8 Schramm N, Born C, Weckbach S, Reilich P, Walter MC, Reiser MF. Involvement patterns in myotilinopathy and desminopathy detected by a novel neuromuscular whole-body MRI protocol. Eur Radiol 2008; 18 (12) 2922-2936
  • 9 Healy PJ, Helliwell PS. Classification of the spondyloarthropathies. Curr Opin Rheumatol 2005; 17 (4) 395-399
  • 10 Braun J, Bollow M, Sieper J. Radiologic diagnosis and pathology of the spondyloarthropathies. Rheum Dis Clin North Am 1998; 24 (4) 697-735
  • 11 Akgul O, Ozgocmen S. Classification criteria for spondyloarthropathies. World J Orthod 2011; 2 (12) 107-115
  • 12 Van den Bosch F, Cryssen BV, Mielants H. Clinical assessment in the spondyloarthropathies, including psoriatic arthritis. Curr Opin Rheumatol 2006; 18 (4) 354-358
  • 13 Nash P, Mease PJ, Braun J, van der Heijde D. Seronegative spondyloarthropathies: to lump or split?. Ann Rheum Dis 2005; 64 (Suppl. 02) ii9-ii13
  • 14 Chatzikyriakidou A, Voulgari PV, Drosos AA. What is the role of HLA-B27 in spondyloarthropathies?. Autoimmun Rev 2011; 10 (8) 464-468
  • 15 Khan MA. Newer clinical and radiographic features of seronegative spondyloarthropathies. Curr Opin Rheumatol 1989; 1 (2) 139-143
  • 16 Eshed I, Bollow M, McGonagle DG , et al. MRI of enthesitis of the appendicular skeleton in spondyloarthritis. Ann Rheum Dis 2007; 66 (12) 1553-1559
  • 17 Zochling J, Baraliakos X, Hermann KG, Braun J. Magnetic resonance imaging in ankylosing spondylitis. Curr Opin Rheumatol 2007; 19 (4) 346-352
  • 18 Krueger JG, Bowcock A. Psoriasis pathophysiology: current concepts of pathogenesis. Ann Rheum Dis 2005; 64 (Suppl. 02) ii30-ii36
  • 19 McGonagle D. Imaging the joint and enthesis: insights into pathogenesis of psoriatic arthritis. Ann Rheum Dis 2005; 64 (Suppl. 02) ii58-ii60
  • 20 McQueen F, Lassere M, Østergaard M. Magnetic resonance imaging in psoriatic arthritis: a review of the literature. Arthritis Res Ther 2006; 8 (2) 207
  • 21 Jevtic V, Watt I, Rozman B, Kos-Golja M, Demsar F, Jarh O. Distinctive radiological features of small hand joints in rheumatoid arthritis and seronegative spondyloarthritis demonstrated by contrast-enhanced (Gd-DTPA) magnetic resonance imaging. Skeletal Radiol 1995; 24 (5) 351-355
  • 22 Becker H, Gaubitz M, Domschke W, Kucharzik T. Joint involvement in chronic inflammatory bowel disease—current diagnostics and treatment options. [in German]. Z Gastroenterol 2006; 44 (6) 497-502
  • 23 Fries W. Inflammatory bowel disease-associated spondyloarthropathies. World J Gastroenterol 2009; 15 (20) 2441-2442
  • 24 Resnick D. Radiology of seronegative spondyloarthropathies. Clin Orthop Relat Res 1979; (143) 38-45
  • 25 Kettering JM, Towers JD, Rubin DA. The seronegative spondyloarthropathies. Semin Roentgenol 1996; 31 (3) 220-228
  • 26 Jevtic V, Rozman B, Kos-Golja M, Watt I. MR imaging in seronegative spondyloarthritis. [in German]. Radiologe 1996; 36 (8) 624-631
  • 27 Braun J, Sieper J, Breban M , et al. Anti-tumour necrosis factor alpha therapy for ankylosing spondylitis: international experience. Ann Rheum Dis 2002; 61 (Suppl. 03) iii51-iii60
  • 28 Braun J, Bollow M, Remlinger G , et al. Prevalence of spondylarthropathies in HLA-B27 positive and negative blood donors. Arthritis Rheum 1998; 41 (1) 58-67
  • 29 Aggarwal R, Malaviya AN. Diagnosis delay in patients with ankylosing spondylitis: factors and outcomes—an Indian perspective. Clin Rheumatol 2009; 28 (3) 327-331
  • 30 Dincer U, Cakar E, Kiralp MZ, Dursun H. Diagnosis delay in patients with ankylosing spondylitis: possible reasons and proposals for new diagnostic criteria. Clin Rheumatol 2008; 27 (4) 457-462
  • 31 Muche B, Bollow M, François RJ, Sieper J, Hamm B, Braun J. Anatomic structures involved in early- and late-stage sacroiliitis in spondylarthritis: a detailed analysis by contrast-enhanced magnetic resonance imaging. Arthritis Rheum 2003; 48 (5) 1374-1384
  • 32 Althoff CE, Sieper J, Song IH , et al. Active inflammation and structural change in early active axial spondyloarthritis as detected by whole-body MRI. Ann Rheum Dis 2012; ; June 26 ( Epub ahead of print)
  • 33 Weber U, Pfirrmann CW, Kissling RO, Hodler J, Zanetti M. Whole body MR imaging in ankylosing spondylitis: a descriptive pilot study in patients with suspected early and active confirmed ankylosing spondylitis. BMC Musculoskelet Disord 2007; 8: 20
  • 34 Hermann KG, Eshed I, Bollow M. Imaging of enthesitis: a new field for the radiologist?. [in German]. Rofo 2006; 178 (6) 578-589
  • 35 Althoff CE, Appel H, Rudwaleit M , et al. Whole-body MRI as a new screening tool for detecting axial and peripheral manifestations of spondyloarthritis. Ann Rheum Dis 2007; 66 (7) 983-985
  • 36 Weckbach SMH, Schewe S, Reiser M, Glaser C. Whole-body MRI in psoriatic arthritis—development of an imaging protocol and evaluation in 25 patients. Skeletal Radiol 2007; 36: 562-563
  • 37 Appel H, Hermann KG, Althoff CE, Rudwaleit M, Sieper J. Whole-body magnetic resonance imaging evaluation of widespread inflammatory lesions in a patient with ankylosing spondylitis before and after 1.  year of treatment with infliximab. J Rheumatol 2007; 34 (12) 2497-2498
  • 38 Klauser A, De Zordo T, Feuchtner G , et al. Feasibility of ultrasound-guided sacroiliac joint injection considering sonoanatomic landmarks at two different levels in cadavers and patients. Arthritis Rheum 2008; 59 (11) 1618-1624
  • 39 Klauser A, Demharter J, De Marchi A , et al; IACUS study group. Contrast enhanced gray-scale sonography in assessment of joint vascularity in rheumatoid arthritis: results from the IACUS study group. Eur Radiol 2005; 15 (12) 2404-2410
  • 40 Ghanem N, Uhl M, Pache G, Bley T, Walker UA, Langer M. MRI in psoriatic arthritis with hand and foot involvement. Rheumatol Int 2007; 27 (4) 387-393
  • 41 Bollow M, Fischer T, Reisshauer H , et al. Quantitative analyses of sacroiliac biopsies in spondyloarthropathies: T cells and macrophages predominate in early and active sacroiliitis—cellularity correlates with the degree of enhancement detected by magnetic resonance imaging. Ann Rheum Dis 2000; 59 (2) 135-140
  • 42 Bredella MA, Steinbach LS, Morgan S, Ward M, Davis JC. MRI of the sacroiliac joints in patients with moderate to severe ankylosing spondylitis. AJR Am J Roentgenol 2006; 187 (6) 1420-1426
  • 43 Hermann KG, Landewé RB, Braun J, van der Heijde DM. Magnetic resonance imaging of inflammatory lesions in the spine in ankylosing spondylitis clinical trials: is paramagnetic contrast medium necessary?. J Rheumatol 2005; 32 (10) 2056-2060
  • 44 Ory PA, Gladman DD, Mease PJ. Psoriatic arthritis and imaging. Ann Rheum Dis 2005; 64 (Suppl. 02) ii55-ii57
  • 45 Hermann KG, Braun J, Fischer T, Reisshauer H, Bollow M. Magnetic resonance tomography of sacroiliitis: anatomy, histological pathology, MR-morphology, and grading. [in German]. Radiologe 2004; 44 (3) 217-228
  • 46 Darge K, Jaramillo D, Siegel MJ. Whole-body MRI in children: current status and future applications. Eur J Radiol 2008; 68 (2) 289-298
  • 47 Sundaram M, McDonald D, Engel E, Rotman M, Siegfried EC. Chronic recurrent multifocal osteomyelitis: an evolving clinical and radiological spectrum. Skeletal Radiol 1996; 25 (4) 333-336
  • 48 Ferguson PJ, Sandu M. Current understanding of the pathogenesis and management of chronic recurrent multifocal osteomyelitis. Curr Rheumatol Rep 2012; 14 (2) 130-141
  • 49 Jurik AG. Chronic recurrent multifocal osteomyelitis. Semin Musculoskelet Radiol 2004; 8 (3) 243-253
  • 50 Fritz J, Tzaribatchev N, Claussen CD, Carrino JA, Horger MS. Chronic recurrent multifocal osteomyelitis: comparison of whole-body MR imaging with radiography and correlation with clinical and laboratory data. Radiology 2009; 252 (3) 842-851
  • 51 Guérin-Pfyffer S, Guillaume-Czitrom S, Tammam S, Koné-Paut I. Evaluation of chronic recurrent multifocal osteitis in children by whole-body magnetic resonance imaging. Joint Bone Spine 2012; ; January 25 ( Epub ahead of print)
  • 52 Amato AA, Barohn RJ. Inclusion body myositis: old and new concepts. J Neurol Neurosurg Psychiatry 2009; 80 (11) 1186-1193
  • 53 Dalakas MC. Review: An update on inflammatory and autoimmune myopathies. Neuropathol Appl Neurobiol 2011; 37 (3) 226-242
  • 54 Dalakas MC. Inflammatory muscle diseases: a critical review on pathogenesis and therapies. Curr Opin Pharmacol 2010; 10 (3) 346-352
  • 55 Dimitri D, Eymard B. Inflammatory myopathies, autoimmune necrotizing myopathies and adult-onset genetic myopathies: differential diagnosis. [in French]. Rev Med Interne 2012; 33 (3) 134-142
  • 56 Dalakas MC. Pathogenesis and therapies of immune-mediated myopathies. Autoimmun Rev 2012; 11 (3) 203-206
  • 57 Greenberg SA. Inflammatory myopathies: evaluation and management. Semin Neurol 2008; 28 (2) 241-249
  • 58 May DA, Disler DG, Jones EA, Balkissoon AA, Manaster BJ. Abnormal signal intensity in skeletal muscle at MR imaging: patterns, pearls, and pitfalls. Radiographics 2000; 20 (Spec No) S295-S315
  • 59 Schulze M, Kötter I, Ernemann U , et al. MRI findings in inflammatory muscle diseases and their noninflammatory mimics. AJR Am J Roentgenol 2009; 192 (6) 1708-1716
  • 60 Peters SA, Köhler C, Schara U , et al. Muscular magnetic resonance imaging for evaluation of myopathies in children. [in German]. Klin Padiatr 2008; 220 (1) 37-46
  • 61 Mercuri E, Bushby K, Ricci E , et al. Muscle MRI findings in patients with limb girdle muscular dystrophy with calpain 3 deficiency (LGMD2A) and early contractures. Neuromuscul Disord 2005; 15 (2) 164-171
  • 62 Mercuri E, Jungbluth H, Muntoni F. Muscle imaging in clinical practice: diagnostic value of muscle magnetic resonance imaging in inherited neuromuscular disorders. Curr Opin Neurol 2005; 18 (5) 526-537
  • 63 Mercuri E, Pichiecchio A, Allsop J, Messina S, Pane M, Muntoni F. Muscle MRI in inherited neuromuscular disorders: past, present, and future. J Magn Reson Imaging 2007; 25 (2) 433-440
  • 64 Mercuri E, Pichiecchio A, Counsell S , et al. A short protocol for muscle MRI in children with muscular dystrophies. Eur J Paediatr Neurol 2002; 6 (6) 305-307
  • 65 O'Connell MJ, Powell T, Brennan D, Lynch T, McCarthy CJ, Eustace SJ. Whole-body MR imaging in the diagnosis of polymyositis. AJR Am J Roentgenol 2002; 179 (4) 967-971
  • 66 Kornblum C, Lutterbey G, Bogdanow M , et al. Distinct neuromuscular phenotypes in myotonic dystrophy types 1 and 2: a whole body highfield MRI study. J Neurol 2006; 253 (6) 753-761
  • 67 Tzaribachev N, Well C, Schedel J, Horger M. Whole-body MRI: a helpful diagnostic tool for juvenile dermatomyositis case report and review of the literature. Rheumatol Int 2009; 29 (12) 1511-1514
  • 68 Ozsarlak O, Parizel PM, De Schepper AM, De Jonghe P, Martin JJ. Whole-body MR screening of muscles in the evaluation of neuromuscular diseases. Eur Radiol 2004; 14 (8) 1489-1493
  • 69 Fischer D, Walter MC, Kesper K , et al. Diagnostic value of muscle MRI in differentiating LGMD2I from other LGMDs. J Neurol 2005; 252 (5) 538-547
  • 70 Connor A, Stebbings S, Anne Hung N, Hammond-Tooke G, Meikle G, Highton J. STIR MRI to direct muscle biopsy in suspected idiopathic inflammatory myopathy. J Clin Rheumatol 2007; 13 (6) 341-345
  • 71 Cronin ME. Musculoskeletal manifestations of systemic lupus erythematosus. Rheum Dis Clin North Am 1988; 14 (1) 99-116
  • 72 Ball EM, Bell AL. Lupus arthritis—do we have a clinically useful classification?. Rheumatology (Oxford) 2012; 51 (5) 771-779
  • 73 Rueda JC, Duque MA, Mantilla RD, Iglesias-Gamarra A. Osteonecrosis and antiphospholipid syndrome. J Clin Rheumatol 2009; 15 (3) 130-132
  • 74 Oh SN, Jee WH, Cho SM , et al. Osteonecrosis in patients with systemic lupus erythematosus: MR imaging and scintigraphic evaluation. Clin Imaging 2004; 28 (4) 305-309
  • 75 Abu-Shakra M, Buskila D, Shoenfeld Y. Osteonecrosis in patients with SLE. Clin Rev Allergy Immunol 2003; 25 (1) 13-24
  • 76 Aranow C, Zelicof S, Leslie D , et al. Clinically occult avascular necrosis of the hip in systemic lupus erythematosus. J Rheumatol 1997; 24 (12) 2318-2322
  • 77 Salesi M, Karimifar M, Mottaghi P, Sayedbonakdar Z, Karimzadeh H. A case of SLE with bilateral osteonecrosis of femoral heads and bone infarct in distal of femur. Rheumatol Int 2010; 30 (4) 527-529
  • 78 Doria A, Iaccarino L, Sarzi-Puttini P, Atzeni F, Turriel M, Petri M. Cardiac involvement in systemic lupus erythematosus. Lupus 2005; 14 (9) 683-686
  • 79 Riboldi P, Gerosa M, Luzzana C, Catelli L. Cardiac involvement in systemic autoimmune diseases. Clin Rev Allergy Immunol 2002; 23 (3) 247-261
  • 80 Lalani TA, Kanne JP, Hatfield GA, Chen P. Imaging findings in systemic lupus erythematosus. Radiographics 2004; 24 (4) 1069-1086
  • 81 Castro TC, Lederman H, Terreri MT, Caldana WI, Kaste SC, Hilário MO. The use of joint-specific and whole-body MRI in osteonecrosis: a study in patients with juvenile systemic lupus erythematosus. Br J Radiol 2011; 84 (1003) 621-628
  • 82 Singh JA, Woodard PK, Dávila-Román VG , et al. Cardiac magnetic resonance imaging abnormalities in systemic lupus erythematosus: a preliminary report. Lupus 2005; 14 (2) 137-144
  • 83 O'Neill SG, Woldman S, Bailliard F , et al. Cardiac magnetic resonance imaging in patients with systemic lupus erythematosus. Ann Rheum Dis 2009; 68 (9) 1478-1481